longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

688253

688253
53.402.20%( -1.20 )

LongbridgeAI

INNOVITA's subsidiary recently obtained a qualification

Zhitong
Jul 18, 2025 at 08:03 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, INNOVITA announced that its wholly-owned subsidiary INNOVITA (Tangshan) Biotechnology Co., Ltd. (referred to as "Tangshan INNOVITA") has recently obtained a new product qualification, with the product name: Norovirus GI/GII Nucleic Acid Detection Kit (PCR Fluorescent Probe Method). The acquisition of this qualification broadens the variety of the company's products and further enhances the company's market expansion capabilities and core competitiveness

According to the announcement from Zhitong Finance APP, INNOVITA (688253.SH) has announced that its wholly-owned subsidiary INNOVITA (Tangshan) Biotechnology Co., Ltd. (referred to as "Tangshan INNOVITA") has recently obtained a new product qualification, with the product name: Norovirus GI/GII Nucleic Acid Detection Kit (PCR Fluorescent Probe Method).

The acquisition of this qualification broadens the variety of the company's products and further enhances the company's market expansion capabilities and core competitiveness

Login to unlock37characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

INNOVITA

INNOVITA

688253.SH

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--